Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents
CA 2384115 C · Owner: Brenner, Michael B. · Inventors: Valencia, Xavier; Brenner, Michael B.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for treating inflammatory joint diseases by inhibiting cadherin-11 mediated cellular function using a cadherin-11 modulating agent is provided. Also provided are screening assays for identifying pharmaceutical lead compounds capable of modulating cellular functions of cadherin-11 such as cell proliferation, apoptosis, factor secretion and binding of cadherin-11 to , cadherin-11 counter-receptor inhibiting binding of cadherin-11 to its counterreceptor either in the context of a cell or in soluble form.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 1, 2000 and granted August 2, 2016. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 1, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 1, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.